GLSI - Greenwich LifeSciences, Inc.
After hours:
| Previous Close | 10.67 |
| Open | 10.68 |
| Bid | 10.72 x 900 |
| Ask | 10.97 x 900 |
| Day's Range | 10.31 - 11.04 |
| 52 Week Range | 6.82 - 21.50 |
| Volume | |
| Avg. Volume | 43,785 |
| Market Cap | 140.945M |
| Beta (5Y Monthly) | 3.49 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.63 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 38.00 |
Simply Wall St.Insiders own 39% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares but retail investors control 42% of the company
Key Insights Significant control over Greenwich LifeSciences by retail investors implies that the general public has...
- Simply Wall St.
Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- Simply Wall St.
Insider Buying: The Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO, CFO & Director Just Bought US$61k Worth Of Shares
Even if it's not a huge purchase, we think it was good to see that Snehal Patel, the CEO, CFO & Director of Greenwich...
Business WireGreenwich LifeSciences Provides Year End Update
STAFFORD, Texas, December 29, 2022--Greenwich LifeSciences Provides Year End Update
ZacksAfter Golden Cross, Greenwich LifeSciences, Inc. (GLSI)'s Technical Outlook is Bright
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Business WireGreenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023
STAFFORD, Texas, December 01, 2022--Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023
- Simply Wall St.
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders seem bullish, own 59% and have been buying more recently
If you want to know who really controls Greenwich LifeSciences, Inc. ( NASDAQ:GLSI ), then you'll have to look at the...
- Simply Wall St.
Bullish insiders at Greenwich LifeSciences, Inc. (NASDAQ:GLSI) loaded up on US$1.4m of stock earlier this year
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
- Simply Wall St.
We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Business WireGreenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial
STAFFORD, Texas, August 11, 2022--Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial
Business WireGreenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial
STAFFORD, Texas, August 03, 2022--Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial
Business WireGreenwich LifeSciences Provides Financing Strategy & Corporate Update
STAFFORD, Texas, July 28, 2022--Greenwich LifeSciences Provides Financing Strategy & Corporate Update
Business WireGreenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed
STAFFORD, Texas, July 12, 2022--Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed
Business WireGreenwich LifeSciences Announces Suspension of Share Repurchase Program
STAFFORD, Texas, July 11, 2022--Greenwich LifeSciences Announces Suspension of Share Repurchase Program